SR Medical Technology Company Limited (0108.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap7.49B
Enterprise Value10.07B
P/E Ratio-36.11
PEG Ratio0.99
Price/Sales Ratio16.76
Price/Book Ratio6.5
Enterprise/Revenue26.17
Enterprise/EBITDA389.11

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.45
Operating Margin-0.11
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.19

Income Statement

Revenue348.91M
Revenue/Share0.12
Gross Profit347.44M
EBITDA18.88M
Net Income-109.63M
Diluted EPS-0.03

Balance Sheet

Total Cash231.06M
Total Cash/Share0.07
Total Debt4.04B
Total Debt/Equity3.97
Current Ratio0.65
Book Value Per Share0.34

Price History

52-Week Change29.11
52-Week High4.28
52-Week Low1.42
Moving Average 50 Days1.75
Moving Average 200 Days2.44

Statistics

Average Volume1.43M
Shares Outstanding3.32B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor283:250
Last Split DateOctober 30, 2015
AD